(Bloomberg) -- New York Community Bancorp’s recovery from a tumultuous year is far from over, but months of work spent trying to transform the lender may finally be paying off. Most Read from Bloomberg NJ Transit, Amtrak Trains Delayed After Derailment Near NYC Where Cargo Bikes Are Freeing Cities From Polluting Vans Exclusive Palo Alto Girls School Borrows $106 Million Eric Adams' Vanishing Promise to Fix NYC's 'Unfair' Property Taxes Waiting for the Miracle of Church-to-Housing Development The Hicksville, New York-based bank’s shares gained as much as 9% on Thursday after Barclays upgraded its rating on the firm to overweight from equal-weight and boosted its price target to $14. The new target matches the highest amount analysts tracked by Bloomberg and implies upside of about 31% from where the stock currently trades. “NYCB has completed the heavy lifting around credit evaluation, capital growth and balance sheet repositioning,” Barclays analyst Jared Shaw wrote in a note to clients. “While the path ahead is still challenging, risk/reward appears in its favor as the bank positions for the future.” Most of Shaw’s peers have moved to the sidelines as the commercial real estate lender worked to right-way its business this year. Out of the 16 analysts tracked by Bloomberg, 13 have a hold rating and the remaining three, including Barclays, have a buy-equivalent recommendation on the stock. Shaw noted that the lender has established a “solid footing” as its added multiple new leaders this year and raised capital through a common and convertible preferred offering. In March, the troubled lender appointed Joseph Otting, the former comptroller of the currency, as its new chief executive officer. Otting replaced Alessandro DiNello, who became CEO less than a week earlier. The shares have been largely range-bound since then, still trading about 65% lower for the year. The stock plunged in January after the company flagged real estate risks that spooked investors. However, fundamentals have been gradually improving for the lender. In the last quarter, NYCB wrote off more for bad loans in the first quarter than estimated, with net charge-offs totaling $81 million, but they came in lower than the fourth-quarter total as well. “NYCB is well on its way to completing the targeted restructure and recapitalization of the balance sheet, but there are still challenges ahead,” Shaw said as he upgraded the stock for the first time since taking coverage in March. Most Read from Bloomberg Businessweek Inside Activision and Blizzard’s Corporate Warcraft This Camera Went Viral Two Years Ago. You Still Can’t Buy One Palantir’s CEO and Wall Street Annoy Each Other Straight to the Bank The End of the Cheap Burger Five Reasons to Be Optimistic About the Entertainment Business ©2024 Bloomberg L.P.
NYCB Shares Rise as Barclays Says ‘Heavy Lifting’ Is Complete
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...